Metrics
Publication
26
Open Access
1
UN Sustainable Development Goals
Dissertations
2020
2020Expertise In Medicine
Nöro-behçet hastalarının klinik ve laboratuvar özelliklerinin analizi
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Research Areas
Neurology
Academic Positions
2025 - Present
2025 - PresentAssistant Professor
Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences
Articles
All (20)
SCI-E, SSCI, AHCI (19)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (1)
Scopus (19)
TRDizin (4)
2025
20251. Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study.
Gozubatik-Celik R. G., Baykan B., Emekli A. S., Tuzun E., Soysal A., Uzunkopru C., et al.
Neurological research
, vol.47, no.7, pp.612-625, 2025 (SCI-Expanded)
2025
20252. Clinical and Laboratory Characteristics of Patients with Neurosarcoidosis Nörosarkoidozlu Hastaların Klinik ve Laboratuvar Özellikleri
Emekli A. S., GÜNDÜZ T., Samanci B., KÜRTÜNCÜ M.
Noropsikiyatri Arsivi
, vol.62, no.2, pp.156-163, 2025 (SCI-Expanded)
2025
20253. Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patients.
Manazoğlu H. C., İşkan G., Gündüz T., Emekli A. S., Akman G., Altunrende B., et al.
Multiple sclerosis and related disorders
, vol.100, pp.106542, 2025 (SCI-Expanded)
2025
20254. Anti-JCV antibody index seroconversion in Turkish multiple sclerosis patients treated with natalizumab
Şahin E., GÜNDÜZ T., Emekli A. S., Ercanoğlu M., Erden S. Ö., KÜRTÜNCÜ M.
NEUROLOGICAL SCIENCES
, vol.46, no.4, pp.1799-1805, 2025 (SCI-Expanded)
2025
20255. Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES)
Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.
EPILEPSY & BEHAVIOR
, vol.163, 2025 (SCI-Expanded)
2025
20256. Cerebral tumefactive demyelinating lesions: clinical spectrum, long-term outcomes, and treatment
Kizek Ö., Emekli A. S., GÜNDÜZ T., KÜRTÜNCÜ M., Eraksoy M.
Acta Neurologica Belgica
, 2025 (SCI-Expanded)
2024
20247. Idiopathic intracranial hypertension without papilledema maybe underdiagnosed
Emekli A. S., Hines D. A., Miller N. J., Schulte A., Kaufman D.
Neurological Sciences
, vol.45, no.10, pp.5077-5081, 2024 (SCI-Expanded)
2024
20248. Pseudotumor Cerebri Due to a Rare Cause of Primary Hypoparathyroidism: Barakat Syndrome.
Emekli A. S., Shmunes M., Goodfellow G., Proctor E., Al-Abdulghani A., Kaufman D.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
, 2024 (SCI-Expanded)
2023
20239. Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve
Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.73, 2023 (SCI-Expanded)
2023
202310. Lesion probability map in cerebral vein thrombosis due to Behcet's disease
Emekli A. S., Dogan F. U., Gunduz T., Sezgin M., Ekizoglu E., Yesilot N., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, vol.26, no.1, pp.145-150, 2023 (SCI-Expanded)
2022
202211. Why electrophysiological reassessment is needed? The experience of our laboratory - A cross-sectional study
Gencdal I., ÖZDAĞ ACARLI A. N., ELMALI YAZICI A. D., Emekli A. S., Oege A. E., BASLO M. B., et al.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.39, no.2, pp.74-78, 2022 (SCI-Expanded)
2022
202212. Lesion Distribution Pattern of Parenchymal Neuro-Behcet's Disease Using Probability Mapping
Emekli A. S., Ersozlu E., Emekli M. A., Gunduz T., Kurtuncu M.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, 2022 (SCI-Expanded)
2021
202113. Olfactory dysfunction in patients with cluster headache
Samancı B., Şahin E., Şen C., Samancı Y., Sezgin M., Emekli S., et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
, no.11, pp.4361-4365, 2021 (SCI-Expanded)
2021
202114. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
Emekli A. S., Parlak A., Gocen N. Y., Kurtuncu M.
NEUROLOGICAL SCIENCES
, no.10, pp.3995-4002, 2021 (SCI-Expanded)
2021
202115. Dopamine Agonist-Associated Hiccup in Parkinson's Disease: A Case Report
Emekli A. S., HANAĞASI H. A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.58, no.3, pp.253-254, 2021 (SCI-Expanded)
2021
202116. A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia
Emekli A. S., Samanci B., Simsir G., Hanagasi H. A., Gurvit H., Bilgic B., et al.
NEUROLOGICAL SCIENCES
, no.4, pp.1535-1539, 2021 (SCI-Expanded)
2021
202117. The clinical significance and electrophysiologic findings of fixation-off and closure of the eyes sensitivity: Data from a prospective unselected population
Dede H. Ö., Bebek N., Emekli S., Baykan B., Yapıcı Z., Gökyiğit A.
Epilepsy Research
, vol.170, 2021 (SCI-Expanded)
2020
202018. Diffuse enlargement of cerebral vasculature in an adult patient operated for cyanotic congenital heart disease
Emekli A. S., Ekizoglu E., Yesilot N.
CARDIOLOGY IN THE YOUNG
, no.5, pp.734-736, 2020 (SCI-Expanded)
2017
201719. Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis
Emekli A. S.
TURKISH JOURNAL OF NEUROLOGY
, no.3, pp.148-149, 2017 (ESCI)
2016
201620. Double-Organ Bias in Published Randomized Controlled Trials of Glaucoma
Esen F., Kostek M., Emekli A. S., ERASLAN M.
JOURNAL OF GLAUCOMA
, no.6, pp.520-522, 2016 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2024
20241. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis
Gündüz T., İşkan N. G., Sevimli A., Büke B., Emekli A. S., Kürtüncü M.
The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Denmark, 18 September 2024, vol.30, pp.4-124, (Summary Text)
2024
20242. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis
GÜNDÜZ T., İŞKAN N. G., Sevimli A., BÜKE B., Emekli A. S., KÜRTÜNCÜ M.
40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, pp.107, (Summary Text)
2023
20233. Uykuda elektriksel status epileptikus hastalarında immün tedavilerin nöropsikiyatrik ve dil bozuklukları üzerine etkisi
Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., Topaloğlu P., Çırak S., et al.
59. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 18 December 2023, pp.19, (Summary Text)
Books
2023
20231. Gen Çevresel Faktörler Etkileşimi - Epigenetik Faktörler
EMEKLİ A. S., KÜRTÜNCÜ M.
in: Multipl skleroz ve kadın, Ayşe Nur Yüceyar, Rana Karabudak, Hüsnü Efendi, Editor, Bilmedya Yayınevi, İstanbul, pp.9-16, 2023
2023
20232. Primer merkezi sinir sistemi vasküliti
EMEKLİ A. S., KÜRTÜNCÜ M.
in: Nöroimmünoloji, Canan Yücesan, Aslı Tuncer, Cihat Uzunköprü, Editor, Nobel Tıp Kitabevi, İstanbul, pp.277-292, 2023
2021
20213. Nörolojik Açıdan Hiperlipidemi
EMEKLİ A. S., EMEKLİ İ.
in: Hiperlipidemi ve Yönetimi, ÖZTÜRK MEHMET AKİF, Editor, Akademisyen Kitabevi, Ankara, pp.27-39, 2021